Systemic injection of MSCs carrying the RANTES-NIS construct into mice harboring subcutaneous HCC xenografts or colon cancer liver metastases led to a significant tumoral radioiodide accumulation, resulting in a delay in tumor growth and improved animal survival [13, 14]. This evidence concerns the gene SLC5A5 and hepatocellular carcinoma.